Merck takes advantage of latest Genedata Biologics functionalities to streamline the design, production, and testing of bispecific antibodies across their therapeutic R&D programs Basel, Switzerland – Genedata, a leading provider of advanced software solutions for R&D, today announced that Merck, a leading science and technology company, has implemented Genedata Biologics™ to scale-up their bispecific antibody […]
Professor Dressman’s appointment enhances Certara’s biopharmaceutics and bioequivalence expertise PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Professor Jennifer B. Dressman, PhD, has been appointed to the Simcyp® Scientific Advisory Board (SAB) to further strengthen its status in the biopharmaceutics field. An expert in biopharmaceutics and a […]
Today we are happy to announce that we have secured USD 5m funding from new and existing investors in an extended series C round. New funds will be used to extend Biognosys commercial operations and to accelerate the development of next generation proteomics workflows and products for high-content and high-throughput protein analysis. “The feedback that […]
Genomic analysis company Genoox has raised $6 million in funding. Inimiti Capital Partners and Glilot Capital Partners led the round. PRESS RELEASE NEW YORK – Today, Genoox, the genomic analysis company on a mission to make it easier and more affordable for doctors, clinicians and researchers to improve patient outcomes using big data, announced a […]
New York – Arsenal Capital Partners (“Arsenal”) today announced that it has agreed to sell its portfolio company, Certara (the “Company”), the leading provider of technology-driven decision support solutions for drug development, to EQT VII Fund for an enterprise value of $850 million. As part of the transaction, Arsenal Capital Partners will retain a minority ownership […]
EQT VII acquires Certara, the global leader in model-informed (in silico) drug development and regulatory science, focused on optimizing drug development and improving health outcomes Certara’s solutions help to inform and accelerate drug development and regulatory approval processes, while addressing the key efficacy, safety, productivity and commercial challenges facing the biopharma industry EQT VII to […]
Extending applications of Genedata Selector from genome knowledge management to novel enzyme discovery and regulatory compliance assessment. Basel, Switzerland Genedata, a leading provider of advanced software solutions for R&D, today announced that it has expanded its partnership with AB Enzymes, one of the world’s oldest and most well-known enzyme manufacturers. AB Enzymes, partnering with Genedata […]
Smart data management company, Eagle Genomics, is pleased to announce the formation of an Advisory Board comprised of some of the world’s thought leaders in data and life sciences. Members of the board are all exceptional individuals representing enterprise, academia, investment and education. The purpose of the Advisory Board is to further the Company’s mission […]
US Government Laboratory Purchases Expanded Package of NOTOCORD Solutions to Extend Safety Pharmacology Testing Capabilities CONSHOHOCKEN, PA – Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has acquired additional NOTOCORD software solutions to expand Safety Pharmacology testing processes at […]
PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has endowed a professorship at the University of Florida College of Pharmacy’s Center for Pharmacometrics and Systems Pharmacology. The professorship will strengthen the relationship between the college’s academic program and industry to drive innovation and enhance the application […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
